When it continues to be unsure whether or not the kidney stone case was immediately due to the quick weight reduction, scientific tests suggest that GLP-1 agonists—the class of medications retatrutide belongs to—could lead to these threats.Another trial participant who lost 31% of their body weight had to regulate their diet, incorporating calo